Artigo Acesso aberto Produção Nacional Revisado por pares

Ocimum gratissimum Linn. and rosmarinic acid, attenuate eosinophilic airway inflammation in an experimental model of respiratory allergy to Blomia tropicalis

2012; Elsevier BV; Volume: 13; Issue: 1 Linguagem: Inglês

10.1016/j.intimp.2012.03.012

ISSN

1878-1705

Autores

Ryan Santos Costa, Tamires Cana Brasil Carneiro, Ana Tereza Cerqueira Lima, Norma Vilany Queiroz, Neuza Maria Alcântara‐Neves, Lain Carlos Pontes-de-Carvalho, Eudes da Silva Velozo, Eduardo de Jesus Oliveira, Camila Alexandrina Figueiredo,

Tópico(s)

Essential Oils and Antimicrobial Activity

Resumo

Allergic asthma has emerged as an important public health problem of urban populations in developed countries. Very often herbal medicine is used to treat this widespread disease, due to the lack of efficacy and the important side effects related to the classical drugs in use. Along this line, Ocimum gratissimum (Og) is a plant widely used in Brazilian folk medicine to treat inflammatory disorders, such as asthma. In the present study we evaluated the immunomodulatory effects of Og and rosmarinic acid (RA, a polyphenolic compound) in a murine model of respiratory allergy induced by the Blomia tropicalis (Bt) mite. The respiratory allergy was induced in A/J mice by administration of Bt extract and the treatment was done using 25, 50 or 100 mg/kg of an Og methanolic extract or using 2, 20 or 200 mg/kg of RA. We then evaluated the changes induced by these drugs on immunological parameters related to the allergic process, which are up-regulated in this allergic model. The treatment of animals with 100 mg/Kg Og and 200 mg/Kg RA led to a significant reduction in the numbers of leukocytes/eosinophils in bronchoalveolar lavage (BAL); eosinophil peroxidase activity in BAL; presence of mucus in respiratory tract, histopathological changes in the lung, and IL-4 in BAL. These results suggest that the methanolic extract of Og and the polyphenol RA have therapeutic potential in this murine model of respiratory allergy to a clinically relevant human sensitizer allergen.

Referência(s)